NCT07070128View on ClinicalTrials.gov

Screening Tool Artificial Intelligence-based for Predicting the Genetic Risk of BREAST Cancer

Not yet recruitingOBSERVATIONAL

Enrollment

800

Participants

Timeline

Start Date

September 16, 2025

Primary Completion Date

August 11, 2026

Study Completion Date

August 11, 2026

Conditions

Breast Neoplasms

Trial Locations (2)

Unknown

Instituto de Ciências Biológicas, Goiânia

90560-032

Associação Hospitalar Moinhos de Vento, Porto Alegre

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY